Gynecologic Cancer News

AI could have the ability to answer some patient questions on cancer instead of clinicians, reducing clinician burdens and improving access to care, according to study results published in JAMA Oncology.

The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.

Federally qualified health centers reported substantially lower breast, cervical and colorectal cancer screenings compared with the general U.S. population, highlighting a gap in screening rates for adults from underrepresented groups.

The addition of pembrolizumab to chemotherapy as adjuvant therapy did not confer significant improvement in DFS compared with placebo in women with newly diagnosed, high-risk endometrial cancer.

As part of routine screening for financial hardship, clinicians should discuss an individual’s employment, access to paid leave and health insurance coverage when constructing a treatment plan relating to cancer care.

Geographic disparities in the availability of cancer clinical trials throughout the United States have worsened over time, according to study data published in JAMA Network Open.

Researchers at Brigham and Women’s Hospital developed a tool that predicts risks for moderate to severe kidney injury after treatment with the chemotherapy drug cisplatin.

Online resources about liquid biopsies have several deficits that could prevent patients from learning about the test and better understanding , according to findings published in JAMA Network Open.

Having a primary care provider raises the likelihood of being up to date on cervical cancer screening, regardless of sexual orientation, but the association was greatest among lesbian, gay and bisexual women, according to researchers.

More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.